Donor NK cell infusion for patients after allogeneic hematopoietic stem cell transplantatio
Phase 1
Recruiting
- Conditions
- acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, chronic myelogenous leukemia
- Registration Number
- JPRN-UMIN000005138
- Lead Sponsor
- Hematology, Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
The performance status is grater or equal to grade 2 (ECOG standard). The patient is on graft-versus-host disease. The patient has severe damages on heart, lung, kidney and liver.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events(grater than or equal to CTCAE grade 3), graft-versus-host disease(grater than or equal to grade 1) and anti-tumor effect
- Secondary Outcome Measures
Name Time Method